Healthcare stocks have long been considered a safe haven for investors looking for stability and growth in their portfolios. Two top healthcare stocks to consider adding to your investment basket right now are Vertex Pharmaceuticals and Johnson & Johnson.
Vertex Pharmaceuticals, known for its cystic fibrosis drug franchise, has seen consistent revenue growth and profitability. With its top-selling drug Trikafta covering a large portion of the patient population in the U.S., the company has a strong foothold in the rare disease drug market. Vertex is also expanding into other areas, such as gene-editing therapies for diseases like sickle cell disease and non-opioid drugs for acute pain. The recent acquisition of Alpine Immune Sciences further solidifies Vertex’s position in the healthcare industry.
On the other hand, Johnson & Johnson, a household name in the pharmaceutical industry, has a long history of success and dividend growth. With a dividend yield of about 3.3% and a track record of increasing dividends for 62 consecutive years, Johnson & Johnson is a dependable addition to any long-term investor’s portfolio. The recent acquisition of Shockwave Medical will further enhance the company’s presence in cardiovascular intervention, adding to its already impressive portfolio of approved products.
Both Vertex Pharmaceuticals and Johnson & Johnson offer investors a combination of stability, growth potential, and a solid track record of success. Consider adding these top healthcare stocks to your investment portfolio for long-term growth and stability.
